The reaffirmed adjusted EPS and EBITDA guidance provides a floor, but the organic sales decline (-2.4%) and 310 bps gross margin compression signal persistent headwinds from tariffs and inflation. Watch for Q3 organic sales trends and whether the restructuring program can deliver margin recovery by year-end.
Price Chart
Executive Summary
Edgewell Personal Care reported Q2 fiscal 2026 results that exceeded internal expectations for sales, adjusted EPS, and EBITDA, but GAAP EPS fell sharply to $0.09 from $0.43 a year ago, and organic net sales declined 2.4%. The company reaffirmed its full-year outlook for organic net sales, adjusted EPS, and adjusted free cash flow, but lowered its GAAP EPS guidance range to $0.00-$0.40 from $0.55-$0.95 due to higher restructuring and legal costs. The stock will likely trade on the reaffirmed adjusted guidance offset by the organic sales decline and compressed margins.
Key Financial Metrics
Key Facts
- Q2 net sales $519.5M, +0.6% reported, but organic net sales -2.4%
- GAAP diluted EPS $0.09 vs $0.43 YoY; adjusted EPS $0.60 vs $0.69 YoY
- Adjusted gross margin fell 310 bps to 43.4% due to inflation, tariffs, and unfavorable mix
- Full-year adjusted EPS outlook reaffirmed at $1.70-$2.10; GAAP EPS guidance lowered to $0.00-$0.40
- Restructuring charges expected to rise to ~$90M for FY2026 (from prior $65M)
- Returned $22.9M to shareholders via $15.8M buybacks and $7.1M dividends in Q2
Financial Impact
Adjusted EPS of $0.60 missed the prior year's $0.69 by 13%, and GAAP EPS collapsed 79% YoY. Full-year GAAP EPS guidance was slashed by ~58% at midpoint.
Risk Factors
- Organic sales declining 2.4% despite favorable FX tailwinds
- Tariff and inflation pressures compressing gross margins by 310 bps
- Restructuring costs ballooning to $90M, up from $65M prior estimate
- GAAP EPS guidance slashed to $0.00-$0.40 from $0.55-$0.95
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001628280-26-030870 |
| Document: epc-20260506.htm | 0001628280-26-030870 |
| Document: 0001628280-26-030870-index-headers.html | 0001628280-26-030870 |
| Document: 0001628280-26-030870-index.html | 0001628280-26-030870 |
| Document: 0001628280-26-030870.txt | 0001628280-26-030870 |
| 8-K Data (Synthetic) | 0001628280-26-030870 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 15, 2026 11d ago | Press Release | $28.10 | awaiting T+20 | — | $27.95 (−0.53%) |
Sep 23, 2026 4w ago | 8-K | $27.08 $26.98 | ▼ −0.37% | ▼ −1.06% | $27.95 (+3.21%) |
Aug 5, 2026 11w ago | 8-K | $29.20 $28.40 | ▼ −2.74% | ▼ −2.14% | $27.95 (−4.28%) |
May 26, 2026 21w ago | 8-K | $17.52 $26.40 | ▲ +50.68% | ▲ +52.63% | $27.95 (+59.53%) |
May 6, 2026 24w ago | 8-K | $22.39 $18.53 | ▼ −17.24% | ▼ −20.02% | $27.95 (+24.83%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers